PubRank

Zelig Eshhar

Author PubWeight™ 36.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res 2006 7.09
2 A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J Immunol 2009 2.43
3 Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J Clin Invest 2004 1.70
4 Redirected tumor-specific allogeneic T cells for universal treatment of cancer. Blood 2011 1.69
5 Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology 2008 1.61
6 Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation. Blood 2004 1.43
7 Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002 1.40
8 Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer 2003 1.19
9 Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 2006 1.18
10 Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 2004 1.15
11 Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem 2004 1.14
12 Growth inhibition of prostate cancer xenografts by halofuginone. Prostate 2002 1.07
13 Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia 2004 1.03
14 Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther 2010 1.03
15 Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Cancer Res 2003 1.01
16 Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor. Gastroenterology 2009 0.97
17 Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. Prostate 2008 0.97
18 Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice. Gastroenterology 2012 0.94
19 Unusual alternative splicing within the human kallikrein genes KLK2 and KLK3 gives rise to novel prostate-specific proteins. J Biol Chem 2002 0.94
20 Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opin Biol Ther 2014 0.92
21 Quantitative detection of protein arrays. Anal Chem 2003 0.88
22 Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors. Prostate 2009 0.87
23 Esterolytic antibodies as mechanistic and structural models of hydrolases-a quantitative analysis. J Mol Biol 2002 0.86
24 Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer. Oncotarget 2011 0.78
25 Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions. Nano Lett 2012 0.77
26 Tumor-specific allogeneic cells for cancer therapy. Expert Opin Biol Ther 2011 0.77
27 CAR's made it to the pancreas. Oncoimmunology 2012 0.75
28 Opinion paper on the current status of the regulation of gene therapy in Europe. Hum Gene Ther 2002 0.75
29 Electrically controlled molecular recognition harnessed to activate a cellular response. Nano Lett 2011 0.75